Efficacy and tolerability of BIC/TAF/FTC in people with HIV and solid and hematological neoplasms: a multicenter observational study (BIKONCO study)
Por:
Monforte, A, Imaz, A, Ferrer, J, Piatti, C, Molero, M, Rodríguez, A, Stable, CE, Navarro, M, Prieto, P, Domingo, P, Crespo, M, Güerri-Fernández, R, Moltó, J and Navarro, J
Publicada:
1 oct 2025
Resumen:
Filiaciones:
Monforte, A:
Hosp Univ Vall dHebron, Infect Dis Dept, Barcelona, Spain
Imaz, A:
Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain
Ferrer, J:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Piatti, C:
Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain
Molero, M:
Hosp Univ Son Llatzer, Mallorca, Spain
Rodríguez, A:
Hosp Univ Son Llatzer, Mallorca, Spain
Stable, CE:
Hosp Univ Parc Tauli, Sabadell, Spain
Navarro, M:
Hosp Univ Parc Tauli, Sabadell, Spain
Prieto, P:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Domingo, P:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Crespo, M:
Hosp Sant Joan de Deu Fundacio Althaia, Manresa, Spain
Güerri-Fernández, R:
Hosp Mar, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Navarro, J:
Hosp Univ Vall dHebron, Infect Dis Dept, Barcelona, Spain
|